Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010

Karen E Lamb1, Stefan Flasche2, Mathew Diggle3

  • 1Department of Mathematics and Statistics, University of Strathclyde, 26 Richmond Street, Glasgow, United Kingdom; Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Royal Children's Hospital, Flemington Road, Parkville, VIC, Australia.

Vaccine
|June 29, 2013
PubMed

Insights

The 7-valent pneumococcal conjugate vaccine (PCV7) significantly reduced invasive pneumococcal disease (IPD) in Scotland, especially in children under 5. Post-vaccination changes in serotypes were linked to pre-existing serotype-ST associations.

Area of Science:

  • Microbiology
  • Epidemiology
  • Vaccinology

Background:

  • The 7-valent pneumococcal conjugate vaccine (PCV7) was integrated into the UK's routine childhood immunization program in 2006.
  • Invasive pneumococcal disease (IPD) surveillance in Scotland provides data on serotype and sequence type (ST) distribution.

Purpose of the Study:

  • To analyze trends in pneumococcal serotypes and multi-locus sequence types (STs) in Scotland before and after PCV7 introduction.
  • To evaluate the impact of PCV7 on IPD incidence across different age groups.

Main Methods:

  • Utilized data from the Scottish Invasive Pneumococcal Disease Enhanced Surveillance system (1999-2010).
  • Employed logistic and Poisson regression modeling to assess temporal trends.
  • Analyzed isolates from blood and cerebrospinal fluid.

Main Results:

  • PCV7 introduction led to a 69% reduction in IPD among children under 5 and a 57% reduction in those aged 5-64.
  • No significant change in IPD incidence was observed in individuals aged 65 and over, with an increase in non-PCV7 serotypes.
  • Post-PCV7 prevalent serotypes were associated with STs linked to the original PCV7 serotypes.

Conclusions:

  • Serotype and ST surveillance in Scotland revealed a relationship between capsule types and bacterial clones post-vaccination.
  • Observed serotype distribution changes are influenced by pre-existing serotype-ST associations.
  • Findings inform predictions for replacement serotypes and the impact of higher-valency vaccines.
Abstract

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...